+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 50Years +
MALE
ID06820606

Randomized Trial Comparing Water Vapour Thermal Therapy Rezum and Prostatic Urethral Lift UroLift for Men With Benign Prostatic Hyperplasia Evaluating Effectiveness and Cost

Led by Chinese University of Hong Kong · Updated on 2026-10-27

120

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a randomized controlled trial to compare two treatments for men with benign prostatic hyperplasia BPH. The study uses a non-inferiority design to evaluate the effectiveness and cost efficiency of water vapour thermal therapy REZUM versus prostatic urethral lift UroLift in male participants aged 50 years or older with symptomatic BPH. Participants will be randomly assigned to one of two groups one receiving the REZUM water vapour treatment and the other receiving the UroLift prostatic urethral lift procedure. Both are device-based treatments aimed at improving urinary symptoms caused by BPH. The study measures outcomes at baseline and at 3, 6, and 12 months after treatment. During the trial, participants will be monitored through various assessments including symptom scores IPSS, quality of life questionnaires, uroflowmetry tests for voiding function, and erectile function evaluations. Researchers will also track hospital stays, catheter use after surgery, complication rates, unplanned readmissions, and overall costs related to the procedures and hospitalization. Follow-up will extend up to 12 months post-treatment to assess changes and safety.

CONDITIONS

Brief Title

Comparing Rezum and Urolift

Research Team

P

Peter Ka-Fung CHIU

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here